C. Nielsen

发表

Does two-segment image reconstruction at 64-section CT coronary angiography improve image quality and diagnostic accuracy?

C. Herzog, T. Flohr, U. Schoepf, 2007, Radiology.

Comparison of lipid deposition at coronary bifurcations versus at nonbifurcation portions of coronary arteries as determined by near-infrared spectroscopy.

J. Goldstein, K. Shunk, E. Brilakis, 2013, The American journal of cardiology.

Prediction of outcome in late-stage cardiomyopathy.

R. Shabetai, C. Nielsen, T. Kelly, 1990, American heart journal.

Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital.

Chetan A. Patel, D. Steinberg, T. Todoran, 2012, The American journal of cardiology.

Defibrillation Thresholds in Hypertrophic Cardiomyopathy

M. Gold, W. Spencer, J. Wharton, 2011, Journal of cardiovascular electrophysiology.

Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure.

Jeffrey A. Jones, M. Zile, A. Maran, 2019, The American journal of cardiology.

Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool

M. Gold, V. Ramakrishnan, J. Rier, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): A Phase 2, Randomized, Sham-Controlled Trial

Sanjiv J. Shah, D. Burkhoff, P. Harst, 2017 .

Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007.

S. Nagueh, W. Spencer, Jennifer L Franklin, 2008, JACC. Cardiovascular interventions.

Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study.

A. Maran, B. Maron, D. Steinberg, 2020, Circulation. Heart failure.

Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: Short‐term results in 50 consecutive procedures

W. Spencer, C. Nielsen, D. Killip, 2003, Clinical Cardiology.

Takotsubo cardiomyopathy in a patient with previously undiagnosed hypertrophic cardiomyopathy with obstruction.

Geoffrey F. Lewis, T. X. O'brien, C. Nielsen, 2011, Cardiovascular revascularization medicine : including molecular interventions.

ollow-Up of Alcohol Septal Ablation or Symptomatic Hypertrophic bstructive Cardiomyopathy he

S. Nagueh, Jennifer L Franklin, C. Nielsen, 2008 .

The curious case of an isolated right coronary artery aneurysm complicated by thrombosis and distal embolization

C. Nielsen, Katrina Bidwell, Mohammad F Mathbout, 2022, Global cardiology science & practice.

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Outcomes in young, middle‐aged, and elderly patients

B. Wolf, Chetan A. Patel, D. Steinberg, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy.

W. Spencer, P. Gazes, C. Nielsen, 2002, The American journal of cardiology.

The role of electrophysiologic study in high‐risk patients with new‐onset conduction disturbances following alcohol septal ablation for hypertrophic obstructive cardiomyopathy

M. Gold, Thomas A. Turnage, P. Badertscher, 2020, Journal of cardiovascular electrophysiology.

Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent

B. Usher, R. Leman, C. Nielsen, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

W. Spencer, C. Nielsen, Valerian L Fernandes, 2003, The American heart hospital journal.

Role of Controlled Septal Infarct in Hypertrophic Obstructive Cardiomyopathy

W. Spencer, C. Nielsen, 2002, Cardiology in review.

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.

Sanjiv J. Shah, D. Burkhoff, J. Massaro, 2017, Circulation.

Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.

M. Gold, S. Nagueh, W. Spencer, 2008, Journal of the American College of Cardiology.

Left ventricular end-diastolic pressure affects measurement of fractional flow reserve.

B. Wolf, Chetan A. Patel, D. Steinberg, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation.

K. Smith, W. Spencer, S. Sears, 2007, The American journal of cardiology.

Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.

B. Groves, K. Smith, R. Bach, 2011, Journal of the American College of Cardiology.

Significant coronary artery stenosis: comparison on per-patient and per-vessel or per-segment basis at 64-section CT angiography.

C. Herzog, U. Schoepf, P. Costello, 2007, Radiology.

Feasible stenting of a large septal perforator providing a sizeable coronary collaterals

C. Nielsen, Abdulrahman Taftafa, H. Hennawi, 2022, Global cardiology science & practice.

Left ventricular end-diastolic pressure affects measurement of fractional flow reserve.

B. Wolf, Chetan A. Patel, D. Steinberg, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.

B. Groves, K. Smith, R. Bach, 2011, Journal of the American College of Cardiology.